Louis Mansky - Publications

Affiliations: 
Molecular, Cellular, Developmental Biology and Genetics University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Virology Biology, Cell Biology, Biochemistry

106 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Meissner ME, Julik EJ, Badalamenti JP, Arndt WG, Mills LJ, Mansky LM. Development of a User-Friendly Pipeline for Mutational Analyses of HIV Using Ultra-Accurate Maximum-Depth Sequencing. Viruses. 13. PMID 34372543 DOI: 10.3390/v13071338  1
2021 Herrmann D, Zhou LW, Hanson HM, Willkomm NA, Mansky LM, Saad JS. Structural Insights into the Mechanism of Human T-cell Leukemia Virus Type 1 Gag Targeting to the Plasma Membrane for Assembly. Journal of Molecular Biology. 433: 167161. PMID 34298060 DOI: 10.1016/j.jmb.2021.167161  0.01
2021 Roth M, McDaniel YZ, Daly MB, Talledge N, Greggs WM, Patterson SE, Kim B, Mansky LM. Distinct antiretroviral mechanisms elicited by a viral mutagen. Journal of Molecular Biology. 167111. PMID 34153286 DOI: 10.1016/j.jmb.2021.167111  1
2021 Lockbaum GJ, Henes M, Talledge N, Rusere LN, Kosovrasti K, Nalivaika EA, Somasundaran M, Ali A, Mansky LM, Kurt Yilmaz N, Schiffer CA. Inhibiting HTLV-1 Protease: A Viable Antiviral Target. Acs Chemical Biology. PMID 33619959 DOI: 10.1021/acschembio.0c00975  1
2020 Harris M, Ratnapriya S, Chov A, Cervera H, Block A, Gu C, Talledge N, Mansky LM, Sodroski J, Herschhorn A. Slow Receptor Binding of the Noncytopathic HIV-2 Envs Is Balanced by Long-Lived Activation State and Efficient Fusion Activity. Cell Reports. 31: 107749. PMID 32521274 DOI: 10.1016/J.Celrep.2020.107749  1
2020 McDaniel YZ, Wang D, Love RP, Adolph MB, Mohammadzadeh N, Chelico L, Mansky LM. Deamination hotspots among APOBEC3 family members are defined by both target site sequence context and ssDNA secondary structure. Nucleic Acids Research. PMID 31943071 DOI: 10.1093/nar/gkz1164  1
2019 Angert I, Karuka SR, Hennen J, Chen Y, Albanesi JP, Mansky LM, Mueller JD. Sensitive Detection of Protein Binding to the Plasma Membrane with Dual-Color Z-Scan Fluorescence. Biophysical Journal. PMID 31870539 DOI: 10.1016/J.Bpj.2019.12.002  1
2019 Shepard C, Xu J, Holler J, Kim DH, Mansky LM, Schinazi RF, Kim B. Effect of induced dNTP pool imbalance on HIV-1 reverse transcription in macrophages. Retrovirology. 16: 29. PMID 31655617 DOI: 10.1186/S12977-019-0491-0  1
2019 McDaniel YZ, Patterson SE, Mansky LM. Distinct dual antiviral mechanism that enhances hepatitis B virus mutagenesis and reduces viral DNA synthesis. Antiviral Research. 104540. PMID 31247245 DOI: 10.1016/J.Antiviral.2019.104540  1
2018 Zhang W, Mendonça LM, Mansky LM. Correction to: The Retrovirus Capsid Core. Sub-Cellular Biochemistry. 88: E1. PMID 30488398 DOI: 10.1007/978-981-10-8456-0_18  1
2018 Wu W, Hatterschide J, Syu YC, Cantara WA, Blower RJ, Hanson HM, Mansky LM, Musier-Forsyth K. Human T-cell leukemia virus type 1 Gag domains have distinct RNA-binding specificities with implications for RNA packaging and dimerization. The Journal of Biological Chemistry. PMID 30217825 DOI: 10.1074/Jbc.Ra118.005531  1
2018 Eichorst JP, Chen Y, Mueller JD, Mansky LM. Distinct Pathway of Human T-Cell Leukemia Virus Type 1 Gag Punctum Biogenesis Provides New Insights into Enveloped Virus Assembly. Mbio. 9. PMID 30181245 DOI: 10.1128/Mbio.00758-18  1
2018 Maldonado JO, Mansky LM. The HIV-1 Reverse Transcriptase A62V Mutation Influences Replication Fidelity and Viral Fitness in the Context of Multi-Drug-Resistant Mutations. Viruses. 10. PMID 30029500 DOI: 10.3390/v10070376  1
2018 Zhang W, Mendonça L, Mansky LL. The Retrovirus Capsid Core. Sub-Cellular Biochemistry. 88: 169-187. PMID 29900497 DOI: 10.1007/978-981-10-8456-0_8  1
2018 Martin JL, Mendonça L, Marusinec R, Zuczek J, Angert I, Blower RJ, Mueller JD, Perilla JR, Zhang W, Mansky LM. Critical Role of the HTLV-1 Capsid N-Terminal Domain for Gag-Gag Interactions and Virus Particle Assembly. Journal of Virology. PMID 29695435 DOI: 10.1128/Jvi.00333-18  1
2017 Maldonado JO, Angert I, Cao S, Berk S, Zhang W, Mueller JD, Mansky LM. Perturbation of Human T-Cell Leukemia Virus Type 1 Particle Morphology by Differential Gag Co-Packaging. Viruses. 9. PMID 28753950 DOI: 10.3390/V9070191  1
2017 Meissner ME, Mendonça L, Zhang W, Mansky LM. Polymorphic Nature of HTLV-1 Particle Cores as Revealed Through Characterization of a Chronically Infected Cell Line. Journal of Virology. PMID 28615198 DOI: 10.1128/Jvi.00369-17  1
2017 Rawson JMO, Gohl DM, Landman SR, Roth ME, Meissner ME, Peterson TS, Hodges JS, Beckman KB, Mansky LM. Single strand consensus sequencing reveals that HIV type but not subtype significantly impacts viral mutation frequencies and spectra. Journal of Molecular Biology. PMID 28502791 DOI: 10.1016/J.Jmb.2017.05.010  1
2017 Martin JL, Mendonça L, Angert I, Mueller JD, Zhang W, Mansky LM. Disparate contributions of human retrovirus capsid subdomains to Gag-Gag oligomerization, virus morphology and particle biogenesis. Journal of Virology. PMID 28446667 DOI: 10.1128/Jvi.00298-17  1
2016 Martin JL, Cao S, Maldonado JO, Zhang W, Mansky LM. Distinct particle morphologies revealed through comparative parallel analyses of retrovirus-like particles. Journal of Virology. PMID 27356903 DOI: 10.1128/Jvi.00666-16  1
2016 Maldonado JO, Cao S, Zhang W, Mansky LM. Distinct Morphology of Human T-Cell Leukemia Virus Type 1-Like Particles. Viruses. 8. PMID 27187442 DOI: 10.3390/V8050132  1
2016 Rawson JM, Roth ME, Xie J, Daly MB, Clouser CL, Landman SR, Reilly CS, Bonnac L, Kim B, Patterson SE, Mansky LM. Synergistic reduction of HIV-1 infectivity by 5-azacytidine and inhibitors of ribonucleotide reductase. Bioorganic & Medicinal Chemistry. PMID 27117260 DOI: 10.1016/J.Bmc.2016.03.052  1
2016 Daly MB, Roth ME, Bonnac L, Maldonado JO, Xie J, Clouser CL, Patterson SE, Kim B, Mansky LM. Dual anti-HIV mechanism of clofarabine. Retrovirology. 13: 20. PMID 27009333 DOI: 10.1186/S12977-016-0254-0  1
2016 Rawson JM, Daly MB, Xie J, Clouser CL, Landman SR, Reilly CS, Bonnac L, Kim B, Patterson SE, Mansky LM. 5-azacytidine enhances the mutagenesis of HIV-1 by reduction to 5-aza-2'-deoxycytidine. Antimicrobial Agents and Chemotherapy. PMID 26833151 DOI: 10.1128/Aac.03084-15  1
2016 Martin JL, Maldonado JO, Mueller JD, Zhang W, Mansky LM. Molecular Studies of HTLV-1 Replication: An Update. Viruses. 8. PMID 26828513 DOI: 10.3390/V8020031  1
2016 Rawson JM, Clouser CL, Mansky LM. Rapid Determination of HIV-1 Mutant Frequencies and Mutation Spectra Using an mCherry/EGFP Dual-Reporter Viral Vector. Methods in Molecular Biology (Clifton, N.J.). 1354: 71-88. PMID 26714706 DOI: 10.1007/978-1-4939-3046-3_6  1
2015 Zhang W, Cao S, Martin JL, Mueller JD, Mansky LM. Morphology and ultrastructure of retrovirus particles. Aims Biophysics. 2: 343-369. PMID 26448965 DOI: 10.3934/biophy.2015.3.343  1
2015 Rawson JM, Landman SR, Reilly CS, Bonnac L, Patterson SE, Mansky LM. Lack of Mutational Hot Spots during Decitabine-Mediated HIV-1 Mutagenesis. Antimicrobial Agents and Chemotherapy. 59: 6834-43. PMID 26282416 DOI: 10.1128/Aac.01644-15  1
2015 Rawson JM, Landman SR, Reilly CS, Mansky LM. HIV-1 and HIV-2 exhibit similar mutation frequencies and spectra in the absence of G-to-A hypermutation. Retrovirology. 12: 60. PMID 26160407 DOI: 10.1186/S12977-015-0180-6  1
2015 Cao S, Maldonado JO, Grigsby IF, Mansky LM, Zhang W. Analysis of human T-cell leukemia virus type 1 particles by using cryo-electron tomography. Journal of Virology. 89: 2430-5. PMID 25473052 DOI: 10.1128/Jvi.02358-14  1
2015 Rawson JMO, Landman SR, Reilly CS, Mansky LM. HIV-1 and HIV-2 exhibit similar mutation frequencies and spectra in the absence of G-to-A hypermutation Retrovirology. DOI: 10.1186/s12977-015-0180-6  1
2014 Rawson JM, Mansky LM. Retroviral vectors for analysis of viral mutagenesis and recombination. Viruses. 6: 3612-42. PMID 25254386 DOI: 10.3390/v6093612  1
2014 Beach LB, Rawson JM, Kim B, Patterson SE, Mansky LM. Novel inhibitors of human immunodeficiency virus type 2 infectivity. The Journal of General Virology. 95: 2778-83. PMID 25103850 DOI: 10.1099/Vir.0.069864-0  1
2014 Maldonado JO, Martin JL, Mueller JD, Zhang W, Mansky LM. New insights into retroviral Gag-Gag and Gag-membrane interactions. Frontiers in Microbiology. 5: 302. PMID 25009535 DOI: 10.3389/Fmicb.2014.00302  1
2014 Tabah AA, Tardif K, Mansky LM. Anti-HIV-1 activity of Trim 37. The Journal of General Virology. 95: 960-7. PMID 24317724 DOI: 10.1099/vir.0.057653-0  1
2014 Fogarty KH, Berk S, Grigsby IF, Chen Y, Mansky LM, Mueller JD. Interrelationship between cytoplasmic retroviral Gag concentration and Gag-membrane association. Journal of Molecular Biology. 426: 1611-24. PMID 24316368 DOI: 10.1016/J.Jmb.2013.11.025  1
2014 Sun M, Grigsby IF, Gorelick RJ, Mansky LM, Musier-Forsyth K. Retrovirus-specific differences in matrix and nucleocapsid protein-nucleic acid interactions: Implications for genomic RNA packaging Journal of Virology. 88: 1271-1280. PMID 24227839 DOI: 10.1128/Jvi.02151-13  1
2014 Dapp MJ, Bonnac L, Patterson SE, Mansky LM. Discovery of novel ribonucleoside analogs with activity against human immunodeficiency virus type 1. Journal of Virology. 88: 354-63. PMID 24155391 DOI: 10.1128/Jvi.02444-13  1
2014 Clouser CL, Bonnac L, Mansky LM, Patterson SE. Characterization of permeability, stability and anti-HIV-1 activity of decitabine and gemcitabine divalerate prodrugs. Antiviral Chemistry & Chemotherapy. 23: 223-30. PMID 23994876 DOI: 10.3851/Imp2682  1
2013 Rawson JM, Heineman RH, Beach LB, Martin JL, Schnettler EK, Dapp MJ, Patterson SE, Mansky LM. 5,6-Dihydro-5-aza-2'-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitors. Bioorganic & Medicinal Chemistry. 21: 7222-8. PMID 24120088 DOI: 10.1016/J.Bmc.2013.08.023  1
2013 Bonnac LF, Mansky LM, Patterson SE. Structure-activity relationships and design of viral mutagens and application to lethal mutagenesis. Journal of Medicinal Chemistry. 56: 9403-14. PMID 23914828 DOI: 10.1021/Jm400653J  1
2013 Holtz CM, Sadler HA, Mansky LM. APOBEC3G cytosine deamination hotspots are defined by both sequence context and single-stranded DNA secondary structure. Nucleic Acids Research. 41: 6139-48. PMID 23620282 DOI: 10.1093/Nar/Gkt246  1
2013 Holtz CM, Mansky LM. Variation of HIV-1 mutation spectra among cell types. Journal of Virology. 87: 5296-9. PMID 23449788 DOI: 10.1128/Jvi.03576-12  1
2013 Dapp MJ, Patterson SE, Mansky LM. Back to the future: revisiting HIV-1 lethal mutagenesis. Trends in Microbiology. 21: 56-62. PMID 23195922 DOI: 10.1016/J.Tim.2012.10.006  1
2013 Dapp MJ, Heineman RH, Mansky LM. Interrelationship between HIV-1 fitness and mutation rate. Journal of Molecular Biology. 425: 41-53. PMID 23084856 DOI: 10.1016/J.Jmb.2012.10.009  1
2012 Clouser CL, Chauhan J, Bess MA, van Oploo JL, Zhou D, Dimick-Gray S, Mansky LM, Patterson SE. Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabine. Bioorganic & Medicinal Chemistry Letters. 22: 6642-6. PMID 23010273 DOI: 10.1016/J.Bmcl.2012.08.108  1
2012 Dapp MJ, Holtz CM, Mansky LM. Concomitant lethal mutagenesis of human immunodeficiency virus type 1. Journal of Molecular Biology. 419: 158-70. PMID 22426127 DOI: 10.1016/J.Jmb.2012.03.003  1
2012 Clouser CL, Holtz CM, Mullett M, Crankshaw DL, Briggs JE, O'Sullivan MG, Patterson SE, Mansky LM. Activity of a novel combined antiretroviral therapy of gemcitabine and decitabine in a mouse model for HIV-1. Antimicrobial Agents and Chemotherapy. 56: 1942-8. PMID 22271861 DOI: 10.1128/Aac.06161-11  1
2012 Greggs WM, Clouser CL, Patterson SE, Mansky LM. Discovery of drugs that possess activity against feline leukemia virus. The Journal of General Virology. 93: 900-5. PMID 22258856 DOI: 10.1099/Vir.0.039909-0  1
2012 Guenzel CA, Hérate C, Le Rouzic E, Maidou-Peindara P, Sadler HA, Rouyez MC, Mansky LM, Benichou S. Recruitment of the nuclear form of uracil DNA glycosylase into virus particles participates in the full infectivity of HIV-1. Journal of Virology. 86: 2533-44. PMID 22171270 DOI: 10.1128/Jvi.05163-11  1
2011 Fogarty KH, Zhang W, Grigsby IF, Johnson JL, Chen Y, Mueller JD, Mansky LM. New insights into HTLV-1 particle structure, assembly, and Gag-Gag interactions in living cells. Viruses. 3: 770-93. PMID 21994753 DOI: 10.3390/V3060770  1
2011 Greggs WM, Clouser CL, Patterson SE, Mansky LM. Broadening the use of antiretroviral therapy: the case for feline leukemia virus. Therapeutics and Clinical Risk Management. 7: 115-22. PMID 21479142 DOI: 10.2147/Tcrm.S17731  1
2011 Wu K, Chen L, Peng G, Zhou W, Pennell CA, Mansky LM, Geraghty RJ, Li F. A virus-binding hot spot on human angiotensin-converting enzyme 2 is critical for binding of two different coronaviruses. Journal of Virology. 85: 5331-7. PMID 21411533 DOI: 10.1128/Jvi.02274-10  1
2011 Fogarty KH, Chen Y, Grigsby IF, Macdonald PJ, Smith EM, Johnson JL, Rawson JM, Mansky LM, Mueller JD. Characterization of cytoplasmic Gag-gag interactions by dual-color z-scan fluorescence fluctuation spectroscopy. Biophysical Journal. 100: 1587-95. PMID 21402042 DOI: 10.1016/J.Bpj.2011.02.008  1
2011 Clouser CL, Holtz CM, Mullett M, Crankshaw DL, Briggs JE, Chauhan J, VanHoutan IM, Patterson SE, Mansky LM. Analysis of the ex vivo and in vivo antiretroviral activity of gemcitabine. Plos One. 6: e15840. PMID 21264291 DOI: 10.1371/Journal.Pone.0015840  1
2011 Dorr CR, Yemets S, Kolomitsyna O, Krasutsky P, Mansky LM. Triterpene derivatives that inhibit human immunodeficiency virus type 1 replication. Bioorganic & Medicinal Chemistry Letters. 21: 542-5. PMID 21084190 DOI: 10.1016/J.Bmcl.2010.10.078  1
2011 Ni Z, Knorr DA, Clouser CL, Hexum MK, Southern P, Mansky LM, Park IH, Kaufman DS. Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms. Journal of Virology. 85: 43-50. PMID 20962093 DOI: 10.1128/Jvi.01774-10  1
2010 Grigsby IF, Zhang W, Johnson JL, Fogarty KH, Chen Y, Rawson JM, Crosby AJ, Mueller JD, Mansky LM. Biophysical analysis of HTLV-1 particles reveals novel insights into particle morphology and Gag stochiometry. Retrovirology. 7: 75. PMID 20854688 DOI: 10.1186/1742-4690-7-75  1
2010 Sanjuán R, Nebot MR, Chirico N, Mansky LM, Belshaw R. Viral mutation rates. Journal of Virology. 84: 9733-48. PMID 20660197 DOI: 10.1128/JVI.00694-10  1
2010 Clouser CL, Patterson SE, Mansky LM. Exploiting drug repositioning for discovery of a novel HIV combination therapy. Journal of Virology. 84: 9301-9. PMID 20610712 DOI: 10.1128/Jvi.01006-10  1
2010 Sadler HA, Stenglein MD, Harris RS, Mansky LM. APOBEC3G contributes to HIV-1 variation through sublethal mutagenesis. Journal of Virology. 84: 7396-404. PMID 20463080 DOI: 10.1128/Jvi.00056-10  1
2010 Grigsby IF, Pham L, Mansky LM, Gopalakrishnan R, Carlson AE, Mansky KC. Tenofovir treatment of primary osteoblasts alters gene expression profiles: implications for bone mineral density loss. Biochemical and Biophysical Research Communications. 394: 48-53. PMID 20171173 DOI: 10.1016/J.Bbrc.2010.02.080  1
2010 Grigsby IF, Pham L, Mansky LM, Gopalakrishnan R, Mansky KC. Tenofovir-associated bone density loss. Therapeutics and Clinical Risk Management. 6: 41-7. PMID 20169035  1
2010 Grigsby IF, Pham L, Gopalakrishnan R, Mansky LM, Mansky KC. Downregulation of Gnas, Got2 and Snord32a following tenofovir exposure of primary osteoclasts. Biochemical and Biophysical Research Communications. 391: 1324-9. PMID 20026012 DOI: 10.1016/J.Bbrc.2009.12.039  1
2009 Dapp MJ, Clouser CL, Patterson S, Mansky LM. 5-Azacytidine can induce lethal mutagenesis in human immunodeficiency virus type 1. Journal of Virology. 83: 11950-8. PMID 19726509 DOI: 10.1128/Jvi.01406-09  1
2009 Chen Y, Wu B, Musier-Forsyth K, Mansky LM, Mueller JD. Fluorescence fluctuation spectroscopy on viral-like particles reveals variable Gag stoichiometry Biophysical Journal. 96: 1961-1969. PMID 19254556 DOI: 10.1016/J.Bpj.2008.10.067  1
2008 Nishiguchi MK, Hirsch AM, Devinney R, Vedantam G, Riley MA, Mansky LM. Deciphering evolutionary mechanisms between mutualistic and pathogenic symbioses Vie Et Milieu. 58: 87-106.  1
2007 Mbisa JL, Barr R, Thomas JA, Vandegraaff N, Dorweiler IJ, Svarovskaia ES, Brown WL, Mansky LM, Gorelick RJ, Harris RS, Engelman A, Pathak VK. Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration. Journal of Virology. 81: 7099-110. PMID 17428871 DOI: 10.1128/Jvi.00272-07  1
2006 Haché G, Mansky LM, Harris RS. Human APOBEC3 proteins, retrovirus restriction, and HIV drug resistance. Aids Reviews. 8: 148-57. PMID 17078485  1
2006 Dorweiler IJ, Ruone SJ, Wang H, Burry RW, Mansky LM. Role of the human T-cell leukemia virus type 1 PTAP motif in Gag targeting and particle release. Journal of Virology. 80: 3634-43. PMID 16537631 DOI: 10.1128/Jvi.80.7.3634-3643.2006  1
2005 Chen R, Yokoyama M, Sato H, Reilly C, Mansky LM. Human immunodeficiency virus mutagenesis during antiviral therapy: impact of drug-resistant reverse transcriptase and nucleoside and nonnucleoside reverse transcriptase inhibitors on human immunodeficiency virus type 1 mutation frequencies. Journal of Virology. 79: 12045-57. PMID 16140780 DOI: 10.1128/Jvi.79.18.12045-12057.2005  1
2005 Jewell NA, Mansky LM. Packaging of heterologous RNAs by a minimal bovine leukemia virus RNA packaging signal into virus particles Archives of Virology. 150: 1161-1173. PMID 15703852 DOI: 10.1007/s00705-004-0476-7  1
2005 Jewell NA, Mansky LM. Construction and characterization of deltaretrovirus indicator cell lines. Journal of Virological Methods. 123: 17-24. PMID 15582694 DOI: 10.1016/j.jviromet.2004.09.002  1
2005 Chen R, Quinones-Mateu ME, Mansky LM. HIV-1 mutagenesis during antiretroviral therapy: implications for successful drug treatment. Frontiers in Bioscience : a Journal and Virtual Library. 10: 743-50. PMID 15569614 DOI: 10.2741/1568  1
2004 Chen R, Quinones-Mateu ME, Mansky LM. Drug resistance, virus fitness and HIV-1 mutagenesis. Current Pharmaceutical Design. 10: 4065-70. PMID 15579088 DOI: 10.2174/1381612043382404  1
2004 Spidel JL, Craven RC, Wilson CB, Patnaik A, Wang H, Mansky LM, Wills JW. Lysines close to the Rous sarcoma virus late domain critical for budding. Journal of Virology. 78: 10606-16. PMID 15367628 DOI: 10.1128/Jvi.78.19.10606-10616.2004  1
2004 Chen R, Le Rouzic E, Kearney JA, Mansky LM, Benichou S. Vpr-mediated incorporation of UNG2 into HIV-1 particles is required to modulate the virus mutation rate and for replication in macrophages. The Journal of Biological Chemistry. 279: 28419-25. PMID 15096517 DOI: 10.1074/Jbc.M403875200  1
2004 Weiss KK, Chen R, Skasko M, Reynolds HM, Lee K, Bambara RA, Mansky LM, Kim B. A role for dNTP binding of human immunodeficiency virus type 1 reverse transcriptase in viral mutagenesis. Biochemistry. 43: 4490-500. PMID 15078095 DOI: 10.1021/Bi035258R  1
2004 Wang H, Machesky NJ, Mansky LM. Both the PPPY and PTAP motifs are involved in human T-cell leukemia virus type 1 particle release. Journal of Virology. 78: 1503-12. PMID 14722305 DOI: 10.1128/Jvi.78.3.1503-1512.2004  1
2003 Jewell NA, Chen R, Raices R, Mansky LM. Nucleoside reverse transcriptase inhibitors and HIV mutagenesis. The Journal of Antimicrobial Chemotherapy. 52: 547-50. PMID 12951341 DOI: 10.1093/Jac/Dkg387  1
2003 Wang H, Norris KM, Mansky LM. Involvement of the matrix and nucleocapsid domains of the bovine leukemia virus Gag polyprotein precursor in viral RNA packaging. Journal of Virology. 77: 9431-8. PMID 12915558 DOI: 10.1128/Jvi.77.17.9431-9438.2003  1
2003 Mansky LM. Mutagenic outcome of combined antiviral drug treatment during human immunodeficiency virus type 1 replication. Virology. 307: 116-21. PMID 12667819 DOI: 10.1016/S0042-6822(02)00069-7  1
2003 Mansky LM, Le Rouzic E, Benichou S, Gajary LC. Influence of reverse transcriptase variants, drugs, and Vpr on human immunodeficiency virus type 1 mutant frequencies. Journal of Virology. 77: 2071-80. PMID 12525642 DOI: 10.1128/JVI.77.3.2071-2080.2003  1
2002 Mansky LM. HIV mutagenesis and the evolution of antiretroviral drug resistance. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 5: 219-23. PMID 12531178 DOI: 10.1016/S1368-7646(02)00118-8  1
2002 Mansky LM, Gajary LC. The primary nucleotide sequence of the bovine leukemia virus RNA packaging signal can influence efficient RNA packaging and virus replication. Virology. 301: 272-80. PMID 12359429 DOI: 10.1006/viro.2002.1578  1
2002 Chen R, Wang H, Mansky LM. Roles of uracil-DNA glycosylase and dUTPase in virus replication. The Journal of General Virology. 83: 2339-45. PMID 12237414 DOI: 10.1099/0022-1317-83-10-2339  1
2002 Mansky LM, Pearl DK, Gajary LC. Combination of drugs and drug-resistant reverse transcriptase results in a multiplicative increase of human immunodeficiency virus type 1 mutant frequencies. Journal of Virology. 76: 9253-9. PMID 12186909 DOI: 10.1128/Jvi.76.18.9253-9259.2002  1
2002 Wang H, Norris KM, Mansky LM. Analysis of bovine leukemia virus gag membrane targeting and late domain function. Journal of Virology. 76: 8485-93. PMID 12134053 DOI: 10.1128/Jvi.76.16.8485-8493.2002  1
2001 Mansky LM, Preveral S, Le Rouzic E, Bernard LC, Selig L, Depienne C, Benarous R, Benichou S. Interaction of human immunodeficiency virus type 1 Vpr with the HHR23A DNA repair protein does not correlate with multiple biological functions of Vpr. Virology. 282: 176-85. PMID 11259200 DOI: 10.1006/viro.2000.0791  1
2001 Mansky LM. Sorting out mutations in human T-cell leukemia virus type 1 proviruses during in vivo clonal expansion Journal of the National Cancer Institute. 93: 336-337. PMID 11238689  1
2000 Mansky LM, Cunningham KS. Virus mutators and antimutatorsroles in evolution, pathogenesis and emergence Trends in Genetics. 16: 512-517. PMID 11074294 DOI: 10.1016/S0168-9525(00)02125-9  1
2000 Mansky LM, Bernard LC. 3'-Azido-3'-deoxythymidine (AZT) and AZT-resistant reverse transcriptase can increase the in vivo mutation rate of human immunodeficiency virus type 1. Journal of Virology. 74: 9532-9. PMID 11000223 DOI: 10.1128/JVI.74.20.9532-9539.2000  1
2000 Mansky LM. In vivo analysis of human T-cell leukemia virus type 1 reverse transcription accuracy Journal of Virology. 74: 9525-9531. PMID 11000222 DOI: 10.1128/JVI.74.20.9525-9531.2000  1
2000 Jewell NA, Mansky LM. In the beginning: Genome recognition, RNA encapsidation and the initiation of complex retrovirus assembly Journal of General Virology. 81: 1889-1899. PMID 10900025  1
2000 Mansky LM, Preveral S, Selig L, Benarous R, Benichou S. The interaction of Vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 in vivo mutation rate Journal of Virology. 74: 7039-7047. PMID 10888643 DOI: 10.1128/JVI.74.15.7039-7047.2000  1
1998 Mansky LM. Retrovirus mutation rates and their role in genetic variation Journal of General Virology. 79: 1337-1345. PMID 9634073  1
1998 Mansky LM, Wisniewski RM. The bovine leukemia virus encapsidation signal is composed of RNA secondary structures Journal of Virology. 72: 3196-3204. PMID 9525645  1
1997 Mansky LM. Accessory replication proteins and the accuracy of reverse transcription: Implications for retroviral genetic diversity Trends in Genetics. 13: 134-136. PMID 9097723 DOI: 10.1016/S0168-9525(97)01062-7  1
1996 Mansky LM. Forward mutation rate of human immunodeficiency virus type 1 in a T lymphoid cell line Aids Research and Human Retroviruses. 12: 307-314. PMID 8906991  1
1996 Mansky LM. The mutation rate of human immunodeficiency virus type 1 is influenced by the vpr gene Virology. 222: 391-400. PMID 8806523 DOI: 10.1006/viro.1996.0436  1
1995 Mansky LM, Krueger AE, Temin HM. The bovine leukemia virus encapsidation signal is discontinuous and extends into the 5′ end of the gag gene Journal of Virology. 69: 3282-3289. PMID 7745675 DOI: 10.1128/Jvi.69.6.3282-3289.1995  1
1995 Mansky LM, Temin HM. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase Journal of Virology. 69: 5087-5094. PMID 7541846 DOI: 10.1128/Jvi.69.8.5087-5094.1995  1
1994 Mansky LM, Temin HM. Lower mutation rate of bovine leukemia virus relative to that of spleen necrosis virus Journal of Virology. 68: 494-499. PMID 8254760 DOI: 10.1128/Jvi.68.1.494-499.1994  1
1993 Mansky LM, Hill JH. Molecular basis for virus disease resistance in plants. Archives of Virology. 131: 1-16. PMID 8328908 DOI: 10.1007/BF01379076  1
1990 Gadani F, Mansky LM, Medici R, Miller WA, Hill JH. Genetic engineering of plants for virus resistance. Archives of Virology. 115: 1-21. PMID 2248549 DOI: 10.1007/BF01310619  1
1990 Mansky LM, Andrews RE, Durand DP, Hill JH. Plant virus location in leaf tissue by press blotting Plant Molecular Biology Reporter. 8: 13-17. DOI: 10.1007/BF02668876  1
Show low-probability matches.